Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy.
Lafarge MW, Domingo E, Sirinukunwattana K, Wood R, Samuel L, Murray G, Richman SD, Blake A, Sebag-Montefiore D, Gollins S, Klieser E, Neureiter D, Huemer F, Greil R, Dunne P, Quirke P, Weiss L, Rittscher J, Maughan T, Koelzer VH. Lafarge MW, et al. Among authors: sebag montefiore d. NPJ Precis Oncol. 2024 Apr 9;8(1):89. doi: 10.1038/s41698-024-00580-3. NPJ Precis Oncol. 2024. PMID: 38594327 Free PMC article.
Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study.
Taylor FG, Quirke P, Heald RJ, Moran BJ, Blomqvist L, Swift IR, Sebag-Montefiore D, Tekkis P, Brown G; Magnetic Resonance Imaging in Rectal Cancer European Equivalence Study Study Group. Taylor FG, et al. J Clin Oncol. 2014 Jan 1;32(1):34-43. doi: 10.1200/JCO.2012.45.3258. Epub 2013 Nov 25. J Clin Oncol. 2014. PMID: 24276776 Clinical Trial.
Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) - protocol for a multi-centre open-label randomised trial.
Hudson EM, Noutch S, Webster J, Brown SR, Boele FW, Al-Salihi O, Baines H, Bulbeck H, Currie S, Fernandez S, Hughes J, Lilley J, Smith A, Parbutt C, Slevin F, Short S, Sebag-Montefiore D, Murray L. Hudson EM, et al. Among authors: sebag montefiore d. BMJ Open. 2024 Mar 8;14(3):e078926. doi: 10.1136/bmjopen-2023-078926. BMJ Open. 2024. PMID: 38458809 Free article.
Preoperative Treatment of Locally Advanced Rectal Cancer.
Sebag-Montefiore D, Cervantes A, Rodel C. Sebag-Montefiore D, et al. N Engl J Med. 2023 Oct 26;389(17):1631. doi: 10.1056/NEJMc2309857. N Engl J Med. 2023. PMID: 37888929 No abstract available.
Patient-reported outcomes in PROSPECT trial (Alliance N1048) - FOLFOX is not a panacea.
O'Cathail SM, Adams R, Hawkins MA, Sebag-Montefiore D, Marijnen CAM, Fokas E. O'Cathail SM, et al. Among authors: sebag montefiore d. Clin Transl Radiat Oncol. 2023 Aug 30;43:100672. doi: 10.1016/j.ctro.2023.100672. eCollection 2023 Nov. Clin Transl Radiat Oncol. 2023. PMID: 37720254 Free PMC article. No abstract available.
Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision.
Gilbert A, Homer V, Brock K, Korsgen S, Geh I, Hill J, Gill T, Hainsworth P, Tutton M, Khan J, Robinson J, Steward M, Cunningham C, Kaur M, Magill L, Russell A, Quirke P, West NP, Sebag-Montefiore D, Bach SP; TREC collaborators. Gilbert A, et al. Among authors: sebag montefiore d. Lancet Healthy Longev. 2022 Dec;3(12):e825-e838. doi: 10.1016/S2666-7568(22)00239-2. Epub 2022 Nov 17. Lancet Healthy Longev. 2022. PMID: 36403589 Free PMC article. Clinical Trial.
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units.
Love SB, Cafferty F, Snowdon C, Carty K, Savage J, Pallmann P, McParland L, Brown L, Masters L, Schiavone F, Hague D, Townsend S, Amos C, South A, Sturgeon K, Langley R, Maughan T, James N, Hall E, Kernaghan S, Bliss J, Turner N, Tutt A, Yap C, Firth C, Kong A, Mehanna H, Watts C, Hills R, Thomas I, Copland M, Bell S, Sebag-Montefiore D, Jones R, Parmar MKB, Sydes MR. Love SB, et al. Among authors: sebag montefiore d. Trials. 2022 Sep 6;23(1):757. doi: 10.1186/s13063-022-06680-4. Trials. 2022. PMID: 36068599 Free PMC article.
Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study.
Theophanous S, Lønne PI, Choudhury A, Berbee M, Dekker A, Dennis K, Dewdney A, Gambacorta MA, Gilbert A, Guren MG, Holloway L, Jadon R, Kochhar R, Mohamed AA, Muirhead R, Parés O, Raszewski L, Roy R, Scarsbrook A, Sebag-Montefiore D, Spezi E, Spindler KG, van Triest B, Vassiliou V, Malinen E, Wee L, Appelt AL; atomCAT consortium. Theophanous S, et al. Among authors: sebag montefiore d. Diagn Progn Res. 2022 Aug 4;6(1):14. doi: 10.1186/s41512-022-00128-8. Diagn Progn Res. 2022. PMID: 35922837 Free PMC article.
185 results